Metastatic Cancer Drug Market: Solid Growth as Targeted Therapies and Immunotherapies Reshape Treatment of Advanced DiseaseThe Metastatic Cancer Drug Market is expanding steadily as targeted therapies and immunotherapies become central to managing advanced cancers. One widely cited analysis values the global metastatic cancer drugs market at about USD 78.75–80.13 billion in 2024–2025, with forecasts reaching USD 120.8–123.5 billion by 2030–2031, at CAGRs around 7.3–7.5%. Some longer-term forecasts point to even higher numbers (USD 187.6 billion in 2026 to USD 421.1 billion by 2035 at ~9.4% CAGR) when broader drug classes and regions are included. https://www.wiseguyreports.com/ko/reports/metastatic-cancer-drug-market